DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
67.78
+1.75 (2.65%)
Oct 8, 2025, 4:00 PM EDT - Market closed
DexCom Market Cap
DexCom has a market cap or net worth of $26.58 billion as of October 8, 2025. Its market cap has decreased by -5.82% in one year.
Market Cap
26.58B
Enterprise Value
26.23B
1-Year Change
-5.82%
Ranking
Category
Stock Price
$67.78
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from $312.50M to $26.58B, an increase of 8,405.69%. That is a compound annual growth rate of 24.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 25.89B | -14.76% |
Dec 31, 2024 | 30.38B | -36.64% |
Dec 29, 2023 | 47.95B | 9.61% |
Dec 30, 2022 | 43.74B | -15.95% |
Dec 31, 2021 | 52.04B | 46.58% |
Dec 31, 2020 | 35.50B | 77.33% |
Dec 31, 2019 | 20.02B | 88.10% |
Dec 31, 2018 | 10.64B | 113.41% |
Dec 29, 2017 | 4.99B | -1.16% |
Dec 30, 2016 | 5.05B | -24.21% |
Dec 31, 2015 | 6.66B | 57.98% |
Dec 31, 2014 | 4.21B | 65.82% |
Dec 31, 2013 | 2.54B | 169.96% |
Dec 31, 2012 | 941.50M | 49.75% |
Dec 30, 2011 | 628.70M | -21.59% |
Dec 31, 2010 | 801.80M | 115.77% |
Dec 31, 2009 | 371.60M | 352.07% |
Dec 31, 2008 | 82.20M | -67.11% |
Dec 31, 2007 | 249.90M | -9.82% |
Dec 29, 2006 | 277.10M | -26.81% |
Dec 30, 2005 | 378.60M | 21.15% |
Apr 14, 2005 | 312.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 759.01B |
Johnson & Johnson | 452.72B |
AbbVie | 412.77B |
UnitedHealth Group | 328.39B |
Novo Nordisk | 269.41B |
AstraZeneca | 265.89B |
Novartis AG | 257.47B |
Abbott Laboratories | 232.28B |